Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perampanel adjunctive therapy in adolescents with partial-onset seizures
2010-018518-56Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Jul 2010
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of perampanel in Focal onset seizure (3 arms), sponsored by Eisai Co., Ltd. Primary endpoint: Primary Safety Analysis - Cognitive Function. Started Jul 2010; status: completed.
02
Drugs
perampanel
03
Conditions
Focal onset seizure
Beyond the preview
Go deeper on 2010-018518-56.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018518-56.